Stock·NASDAQ·Financial Services
Affirm Holdings, Inc. (AFRM)
- Market cap
- $25.62B
- P/E
- 14.08
- Dividend yield
- 0.00%
- Street target
- $100.00median of 34 analysts
- 52-week range
- $42.10 $90.44
The short version
Where AFRM stands today, in four lines, and what CleaRank Financial AI makes of it.
AFRM at a glance
Affirm Holdings, Inc. (AFRM): Buy, 74/100 on CleaRank's AI score.
- Trend Up: the price is above both its 50- and 200-day moving averages ($73.76 and $66.81).
- Insiders Insiders sold $187.3M and made no open-market purchases over the last 18 months.
- Valuation P/E of 14.1 against 16.5 for the Financial Services sector: broadly in line with peers (-15%).
Figures as of October 16, 2026.
CleaRank Financial AI
Only on CleaRank
Figures we compute ourselves from AFRM's own price, earnings and insider-filing history. Tap one to see it in context.
Price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
4/4Price above its 50-day average ›
The price of $75.92 is 2.9% above the 50-day simple moving average of $73.76.Price above its 200-day average ›
The price is 13.6% above the 200-day simple moving average of $66.81.50-day average above the 200-day ›
The 50-day average ($73.76) is 10.4% above the 200-day average ($66.81), the arrangement of a rising longer-term trend.In the upper half of its 52-week range ›
The price sits at 70% of its 52-week range, between $42.10 and $90.44.
AFRM share price
Pick a period: each tab shows how far AFRM has moved over it, to the last close.
Today's trading
Where AFRM sits inside today's range and its 52-week range.
Fundamentals
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
2/3P/E below the sector median ›
The trailing P/E of 14.08 is 14.6% below the Financial Services median of 16.5.P/S below the sector median ›
The price-to-sales ratio of 6.17 is 62.3% above the sector median of 3.8.Profitable over the last 12 months ›
Net income over the last 12 months was $1.9B on revenue of $4.3B, a net margin of 45.3%.
Key statistics
The headline figures for AFRM.
As of October 16, 2026, AFRM trades at $75.92, with a market value of $25.62B and a P/E ratio of 14.08.
What the numbers say
CleaRank Financial AI's reading of AFRM's valuation, growth and risks.
Affirm Holdings, Inc. exhibits strong revenue growth of 33%, significantly exceeding the sector median of 11.7%.
Its Price-to-Sales ratio of 6.17 is higher than the sector median of 3.8, indicating a premium valuation. The company's Return on Equity (ROE) is an impressive 45.13%, far surpassing the sector average of 13.8%, and its Net Profit Margin stands at 45.29%, demonstrating strong profitability. The Debt-to-Equity ratio of 1.83 is in line with the sector average. While the company's profitability and growth are strong, the higher P/S ratio suggests that investors are pricing in future growth, making valuation a key consideration.
AFRM against the Financial Services sector
How AFRM compares with the median Financial Services stock CleaRank tracks.
Price to earnings vs sector: Valuation is broadly in line with sector peers (-15% difference), suggesting fair market pricing relative to industry standards.
Return vs KBE: Since May 5, 2025, AFRM has gained 45.8% against a gain of 21.5% for KBE.
Performance against KBE
AFRM and the Financial Services sector fund over the same days.
Revenue and earnings
How much AFRM sells, and how much of it becomes profit.
Revenue growth: Revenue grew 38.8% in FY2025 to $3.2B, from $2.3B a year earlier.
Profit margin: The net margin was 1.6% in FY2025, up from -22.3% the year before.
Profitable: AFRM earned $52.2M in FY2025.
Earnings reality check
Did AFRM beat what analysts expected, and how did the stock react?
Earnings record: AFRM beat the analyst estimate in 2 of the last 2 quarters.
Market reaction: The stock rose in the first session after every beat.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Aug 28, 2025after close | $0.43 | $0.53 | +23.26% | +10.59% | +9.20% |
| Feb 6, 2025after close | $0.43 | $0.76 | +76.74% | +21.81% | +28.39% |
Reports after August 28, 2025 are not yet in our data.
As of October 16, 2026, AFRM has beaten the analyst EPS estimate in 2 of its last 2 reported quarters and rose in the first trading session after every one of those beats; its most recent report in our data, on August 28, 2025, came in 23.26% above the estimate and the stock moved +10.59% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
AI analysis and technicals
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
3/3RSI not overbought or oversold ›
The 14-day RSI is 53.5, in neutral territory.RSI above 50 ›
An RSI of 53.5 is above the 50 midpoint, so buyers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is positive, so the 12-day average is above the 26-day average.
CleaRank AI analysis of AFRM
The score, the reasoning behind it, and what could move the price next.
Affirm Holdings, Inc. is currently trading above its 50-day SMA of $73.76 and its 200-day SMA of $66.81, suggesting an upward trend.
The 14-day RSI is at 53.5, indicating neutral momentum. The MACD is at 0.97, also suggesting a neutral to slightly positive momentum. Volume on the latest trading day was 5,916,513, which is 36.6% above the average volume, indicating increased investor interest. Key support levels are near the 50-day SMA, while resistance may be found near recent highs. The current technical setup suggests a stable trading environment with potential for further upside if bullish momentum continues.
Strong Revenue Growth Exceeding Sector Median ›
Affirm Holdings, Inc. reported 33% revenue growth, significantly outpacing the Financial Services sector median of 11.7%, indicating strong market traction and expansion potential.
Source: Company DataPositive Earnings Surprise ›
The company's most recent available earnings report on August 28, 2025, showed an EPS beat of 23.26%, leading to a positive stock price reaction and reinforcing analyst confidence.
Source: Company DataHigh Analyst Price Target Upside ›
The median Wall Street price target for Affirm Holdings, Inc. is $100.00, representing a potential upside of 31.7% from the current stock price, supported by a 'Buy' consensus rating.
Source: Wall Street Summary
Premium Valuation ›
Affirm Holdings, Inc.'s Price-to-Sales ratio of 6.17 is considerably higher than the sector median of 3.8, suggesting the stock may be overvalued if future growth expectations are not met.
Source: Company Data & Sector Averages
Technical indicators
Momentum and trend for AFRM, from its daily closes.
As of October 16, 2026, with AFRM at $75.92, its 14-day RSI is 53.5 (neutral territory), its 50-day simple moving average is $73.76 and its 200-day is $66.81.
Calculated by CleaRank on daily closes as of October 16, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26).
What AFRM moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 16, 2026, AFRM's 1-year correlation of daily returns is +0.58 with S&P 500 (SPY), +0.55 with Nasdaq 100 (QQQ), +0.34 with Bitcoin (BTC) and +0.06 with gold (XAU).
What Wall Street expects
The analysts' target range and how their ratings split.
Analysts checks
3/3Most analysts rate it a buy ›
27 of 34 analysts rate it a buy or strong buy, 7 a hold and 0 a sell.Median target above the price ›
The median 12-month target of $100.00 is 31.7% above the price.More buy ratings than three months ago ›
27 of 34 rate it a buy now, against 25 of 34 three months ago.
AFRM Wall Street View
12-month price targets
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 13, 2026 | Goldman Sachs | Maintains | Buy |
| Oct 6, 2026 | TD Cowen | Maintains | Buy |
| Oct 1, 2026 | Freedom Capital Markets | Maintains | Buy |
| Sep 16, 2026 | Citizens | Reiterates | Market Outperform |
| Sep 14, 2026 | Wolfe Research | Upgrade | Outperform |
| Sep 9, 2026 | Loop Capital | Initiates | Buy |
As of October 16, 2026, 34 Wall Street analysts cover AFRM: 27 rate it a buy or strong buy, 7 a hold and 0 a sell or strong sell. Their 12-month price targets range from $66.00 to $115.00, with a median of $100.00, 31.7% above the price of $75.92.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
A trade plan, if you want one
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
AFRM trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Long entry pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
AFRM moves about 3.7% a day on average, so a stop can fill well past its level. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much AFRM tends to move, against the market and on its own.
The long record
AFRM's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
0/4Average daily move under 2% ›
The price has moved 3.70% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 94.6%, from November 2021 to May 2023; the price is still 54.9% below that peak.Most 1-year holds ended higher ›
55% of 1-year holding periods in the last 6 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in January 2021 is now worth $7,878.38, against $21,934 in the S&P 500 (SPY).
AFRM Drawdowns & Recovery
As of October 16, 2026, AFRM's worst peak-to-trough fall over the last 6 years with dividends reinvested was -94.6% (November 2021 to May 2023); it is still 54.9% below that peak, and 55% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into AFRM in January 2021 is worth now, against the same amount in the S&P 500.
Against the market: AFRM trailed the S&P 500 over this period: $7,878.38 against $21,934.
A $10,000 investment in AFRM in January 2021 would be worth about $7,878 today with dividends reinvested, compared with about $21,934 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to AFRM, and which have not.
Strongest month, November: an average of +22.05%, up in 3 of 5 years.
Weakest month, February: an average of -14.91%, up in 1 of 6 years.
This month, October: has averaged +2.11%, up in 2 of 5 years. Past seasonality does not repeat on schedule.
Over the last 6 years, AFRM's strongest calendar month has been November (average +22.05%, up in 3 of 5 years) and its weakest February (average -14.91%, up in 1 of 6 years).
Average return for each calendar month over the last 6 years, from weekly closing prices with dividends included.
Long-term scenarios
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in AFRM, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in AFRM today could grow to about $10,783 by 2036 in the base case, with a 90th-percentile outcome near $81,806 and a 10th-percentile outcome around $1,421. Projections are statistical simulations, not guarantees.
AFRM Stock Price Prediction: 2030
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $78.24 for AFRM by 2030 in the base case, from $75.92 today (1.0x over 4 years). The 10th-percentile path ends near $21.72. These are outcomes of a Monte Carlo simulation run on AFRM's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $40.30 | $76.49 | $145 | |
| 2028 | $31.14 | $77.07 | $191 | |
| 2029 | $25.59 | $77.66 | $236 | |
| 2030 | $21.72 | $78.24 | $282 | |
| 2031 | $18.81 | $78.84 | $330 |
Method: a lognormal simulation of AFRM's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles.
Insider trading
What the people running the company have bought and sold.
AFRM insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Insider buying: No insider bought AFRM shares on the open market in the last 18 months. Sales are often planned in advance or cover tax on vesting shares, so they say less than purchases would.
As of October 16, 2026, AFRM insiders reported 33 open-market sales worth $187.3M and no open-market purchases over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Sep 14, 2026 | Siphelele N Jiyane
Officer
|
Sell | 27.0K | $1.9M |
| Sep 4, 2026 | Siphelele N Jiyane
Officer
|
Sell | 25.0K | $1.8M |
| Sep 3, 2026 | Katherine Elizabeth Adkins
Officer
|
Sell | 83.3K | $6.1M |
| Sep 3, 2026 | Katherine Elizabeth Adkins
Officer
|
Option | 93.9K | $1.9M |
| Sep 2, 2026 | Robert Warren O'Hare
Chief Financial Officer
|
Sell | 21.6K | $1.6M |
| Sep 1, 2026 | Siphelele N Jiyane
Officer
|
Grant | 9.0K | - |
| Sep 1, 2026 | Michael Alan Linford
President
|
Grant | 11.7K | - |
| Sep 1, 2026 | Libor Michalek
President
|
Grant | 11.4K | - |
| Sep 1, 2026 | Robert Warren O'Hare
Chief Financial Officer
|
Grant | 12.0K | - |
| Aug 28, 2026 | Michael Alan Linford
Chief Operating Officer
|
Sell | 79.2K | $7.1M |
| Aug 28, 2026 | Michael Alan Linford
Chief Operating Officer
|
Option | 79.2K | $427.0K |
| Aug 12, 2026 | Noel Bertram Watson Jr
Director
|
Sell | 2.0K | $155.7K |
| Jul 31, 2026 | Katherine Elizabeth Adkins
Officer
|
Grant | 1.4K | - |
| Jul 31, 2026 | Michael Alan Linford
Chief Operating Officer
|
Grant | 2.3K | - |
| Jul 31, 2026 | Libor Michalek
President
|
Grant | 2.3K | - |
| Jul 1, 2026 | Katherine Elizabeth Adkins
Officer
|
Grant | 1.4K | - |
| Jul 1, 2026 | Richard Alan Galanti
Director
|
Grant | 655 | - |
| Jul 1, 2026 | Jeremy Liew
Director
|
Grant | 655 | - |
| Jul 1, 2026 | Michael Alan Linford
Chief Operating Officer
|
Grant | 2.3K | - |
| Jul 1, 2026 | Libor Michalek
President
|
Grant | 2.3K | - |
| Jul 1, 2026 | Christa S. Quarles
Director
|
Grant | 655 | - |
| Jul 1, 2026 | Jacqueline D Reses
Director
|
Grant | 655 | - |
| Jul 1, 2026 | Ryan M. Schneider
Director
|
Grant | 3.8K | - |
| Jun 26, 2026 | Michael Alan Linford
Chief Operating Officer
|
Sell | 100.0K | $8.0M |
| Jun 26, 2026 | Michael Alan Linford
Chief Operating Officer
|
Option | 100.0K | $539.0K |
| Jun 1, 2026 | Katherine Elizabeth Adkins
Officer
|
Grant | 10.6K | - |
| Jun 1, 2026 | Siphelele N Jiyane
Officer
|
Grant | 11.5K | - |
| Jun 1, 2026 | Michael Alan Linford
Chief Operating Officer
|
Grant | 11.7K | - |
| Jun 1, 2026 | Libor Michalek
President
|
Grant | 11.4K | - |
| Jun 1, 2026 | Robert Warren O'Hare
Chief Financial Officer
|
Grant | 16.4K | - |
| May 13, 2026 | Noel Bertram Watson Jr
Director
|
Sell | 2.0K | $130.0K |
| May 1, 2026 | Katherine Elizabeth Adkins
Officer
|
Grant | 1.4K | - |
| May 1, 2026 | Michael Alan Linford
Chief Operating Officer
|
Grant | 2.3K | - |
| May 1, 2026 | Libor Michalek
President
|
Grant | 2.3K | - |
| Apr 14, 2026 | Noel Bertram Watson Jr
Director
|
Sell | 2.0K | $110.0K |
| Apr 2, 2026 | Christa S. Quarles
Director
|
Grant | 60.4K | - |
| Apr 1, 2026 | Katherine Elizabeth Adkins
Officer
|
Grant | 1.4K | - |
| Apr 1, 2026 | Michael Alan Linford
Chief Operating Officer
|
Grant | 2.3K | - |
| Apr 1, 2026 | Libor Michalek
President
|
Grant | 2.3K | - |
| Feb 27, 2026 | Katherine Elizabeth Adkins
Officer
|
Grant | 10.6K | - |
| Feb 27, 2026 | Siphelele N Jiyane
Officer
|
Grant | 11.5K | - |
| Feb 27, 2026 | Michael Alan Linford
Chief Operating Officer
|
Grant | 11.7K | - |
| Feb 27, 2026 | Libor Michalek
President
|
Grant | 11.4K | - |
| Feb 27, 2026 | Robert Warren O'Hare
Chief Financial Officer
|
Grant | 18.4K | - |
| Feb 9, 2026 | Michael Alan Linford
Chief Operating Officer
|
Option | 20.0K | $980.0K |
| Jan 30, 2026 | Katherine Elizabeth Adkins
Officer
|
Grant | 1.4K | - |
| Jan 30, 2026 | Michael Alan Linford
Chief Operating Officer
|
Option | 20.0K | $980.0K |
| Jan 30, 2026 | Michael Alan Linford
Chief Operating Officer
|
Grant | 2.3K | - |
| Jan 30, 2026 | Libor Michalek
President
|
Grant | 2.3K | - |
| Jan 5, 2026 | Maksim Rafael Levchin
Chief Executive Officer
|
Sell | 666.7K | $53.7M |
| Jan 5, 2026 | Robert Warren O'Hare
Chief Financial Officer
|
Sell | 36.4K | $2.9M |
| Jan 5, 2026 | Maksim Rafael Levchin
Chief Executive Officer
|
Option | 666.7K | $32.7M |
| Jan 5, 2026 | Robert Warren O'Hare
Chief Financial Officer
|
Option | 36.4K | $1.0M |
| Dec 31, 2025 | Katherine Elizabeth Adkins
Officer
|
Grant | 1.7K | - |
| Dec 31, 2025 | Michael Alan Linford
Chief Operating Officer
|
Grant | 2.3K | - |
| Dec 31, 2025 | Libor Michalek
President
|
Grant | 2.3K | - |
| Dec 15, 2025 | Richard Alan Galanti
Director
|
Grant | 3.6K | - |
| Dec 15, 2025 | Brian D. Hughes
Director
|
Grant | 3.6K | - |
| Dec 15, 2025 | Jeremy Liew
Director
|
Grant | 3.6K | - |
| Dec 15, 2025 | Christa S. Quarles
Director
|
Grant | 3.6K | - |
| Dec 15, 2025 | Jacqueline D Reses
Director
|
Grant | 3.6K | - |
| Dec 15, 2025 | Rodriquez Manuel Sanchez
Director
|
Grant | 3.6K | - |
| Dec 15, 2025 | Noel Bertram Watson Jr
Director
|
Grant | 3.6K | - |
| Dec 3, 2025 | Robert Warren O'Hare
Chief Financial Officer
|
Sell | 8.2K | $573.2K |
| Dec 1, 2025 | Katherine Elizabeth Adkins
Officer
|
Grant | 10.9K | - |
| Dec 1, 2025 | Siphelele N Jiyane
Officer
|
Grant | 11.5K | - |
| Dec 1, 2025 | Michael Alan Linford
Chief Operating Officer
|
Grant | 11.7K | - |
| Dec 1, 2025 | Libor Michalek
President
|
Grant | 11.4K | - |
| Dec 1, 2025 | Robert Warren O'Hare
Chief Financial Officer
|
Grant | 19.4K | - |
| Oct 31, 2025 | Katherine Elizabeth Adkins
Officer
|
Grant | 1.7K | - |
| Oct 31, 2025 | Michael Alan Linford
Chief Operating Officer
|
Grant | 2.3K | - |
| Oct 31, 2025 | Libor Michalek
President
|
Grant | 2.3K | - |
| Oct 1, 2025 | Katherine Elizabeth Adkins
Officer
|
Grant | 1.7K | - |
| Oct 1, 2025 | Michael Alan Linford
Chief Operating Officer
|
Grant | 2.3K | - |
| Oct 1, 2025 | Libor Michalek
President
|
Grant | 2.3K | - |
| Sep 15, 2025 | Siphelele Jiyane
Officer
|
Sell | 12.5K | $1.1M |
| Sep 5, 2025 | Michael Alan Linford
Chief Operating Officer
|
Grant | 77.7K | - |
| Sep 4, 2025 | Siphelele Jiyane
Officer
|
Sell | 25.5K | $2.3M |
| Sep 4, 2025 | Siphelele Jiyane
Officer
|
Option | 25.5K | $84.3K |
| Sep 2, 2025 | Robert W O'Hare
Chief Financial Officer
|
Sell | 31.4K | $2.6M |
| Sep 2, 2025 | Robert W O'Hare
Chief Financial Officer
|
Option | 43.1K | $737.2K |
| Aug 29, 2025 | Katherine Elizabeth Adkins
Officer
|
Sell | 36.9K | $3.5M |
| Aug 29, 2025 | Siphelele Jiyane
Officer
|
Sell | 22.7K | $2.2M |
| Aug 29, 2025 | Christa S. Quarles
Director
|
Sell | 15.0K | $1.4M |
| Aug 29, 2025 | Katherine Elizabeth Adkins
Officer
|
Option | 53.6K | $861.1K |
| Aug 29, 2025 | Siphelele Jiyane
Officer
|
Grant | 11.5K | - |
| Aug 29, 2025 | Michael Alan Linford
Chief Operating Officer
|
Grant | 25.0K | - |
| Aug 29, 2025 | Libor Michalek
President
|
Grant | 23.6K | - |
| Aug 28, 2025 | Max R Levchin
Chief Executive Officer
|
Sell | 499.2K | $40.0M |
| Aug 28, 2025 | Max R Levchin
Chief Executive Officer
|
Option | 499.2K | $24.5M |
| Aug 22, 2025 | Michael Alan Linford
Chief Operating Officer
|
Sell | 184.2K | $14.8M |
| Aug 22, 2025 | Max R Levchin
Chief Executive Officer
|
Sell | 167.4K | $13.4M |
| Aug 22, 2025 | Robert W O'Hare
Chief Financial Officer
|
Sell | 77.8K | $6.2M |
| Aug 22, 2025 | Max R Levchin
Chief Executive Officer
|
Option | 167.4K | $8.2M |
| Aug 22, 2025 | Michael Alan Linford
Chief Operating Officer
|
Option | 184.2K | $992.8K |
| Aug 22, 2025 | Robert W O'Hare
Chief Financial Officer
|
Option | 77.8K | $2.5M |
| Aug 18, 2025 | Max R Levchin
Chief Executive Officer
|
Sell | 15.0K | $1.2M |
| Aug 18, 2025 | Robert W O'Hare
Chief Financial Officer
|
Sell | 11.4K | $912.4K |
| Aug 18, 2025 | Michael Alan Linford
Chief Operating Officer
|
Sell | 10.8K | $864.0K |
| Aug 18, 2025 | Max R Levchin
Chief Executive Officer
|
Option | 15.0K | $732.7K |
| Aug 18, 2025 | Michael Alan Linford
Chief Operating Officer
|
Option | 10.8K | $58.2K |
| Aug 18, 2025 | Robert W O'Hare
Chief Financial Officer
|
Option | 11.4K | $567.4K |
| Aug 6, 2025 | Katherine Elizabeth Adkins
Officer
|
Sell | 6.5K | $486.7K |
| Aug 6, 2025 | Katherine Elizabeth Adkins
Officer
|
Option | 6.5K | $151.4K |
| Aug 5, 2025 | Katherine Elizabeth Adkins
Officer
|
Sell | 60.6K | $4.5M |
| Aug 5, 2025 | Katherine Elizabeth Adkins
Officer
|
Option | 62.3K | $1.4M |
| Aug 4, 2025 | Siphelele Jiyane
Officer
|
Sell | 15.9K | $1.2M |
| Aug 1, 2025 | Michael Alan Linford
Chief Operating Officer
|
Grant | 2.3K | - |
| Aug 1, 2025 | Libor Michalek
President
|
Grant | 2.3K | - |
| Jul 7, 2025 | Katherine Elizabeth Adkins
Officer
|
Sell | 57.1K | $4.0M |
| Jul 7, 2025 | Robert W O'Hare
Chief Financial Officer
|
Sell | 19.8K | $1.4M |
| Jul 7, 2025 | Katherine Elizabeth Adkins
Officer
|
Option | 57.1K | $895.4K |
| Jul 1, 2025 | Christa S. Quarles
Director
|
Sell | 754 | $50.8K |
| Jul 1, 2025 | Katherine Elizabeth Adkins
Officer
|
Grant | 1.7K | - |
| Jul 1, 2025 | Richard Alan Galanti
Director
|
Grant | 8.1K | - |
| Jul 1, 2025 | Jeremy Liew
Director
|
Grant | 670 | - |
| Jul 1, 2025 | Michael Alan Linford
Chief Operating Officer
|
Grant | 8.9K | - |
| Jul 1, 2025 | Libor Michalek
President
|
Grant | 10.8K | - |
| Jul 1, 2025 | Robert W O'Hare
Chief Financial Officer
|
Grant | 3.8K | - |
| Jul 1, 2025 | Christa S. Quarles
Director
|
Grant | 670 | - |
Source: TwelveData, from SEC Form 4 filings
Questions people ask
Answered from the figures on this page, as of October 16, 2026.